CA2963980A1 - Monounsaturated fatty acid compositions and use for treating atherosclerosis - Google Patents

Monounsaturated fatty acid compositions and use for treating atherosclerosis Download PDF

Info

Publication number
CA2963980A1
CA2963980A1 CA2963980A CA2963980A CA2963980A1 CA 2963980 A1 CA2963980 A1 CA 2963980A1 CA 2963980 A CA2963980 A CA 2963980A CA 2963980 A CA2963980 A CA 2963980A CA 2963980 A1 CA2963980 A1 CA 2963980A1
Authority
CA
Canada
Prior art keywords
composition
weight
group
mufa
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2963980A
Other languages
English (en)
French (fr)
Inventor
John M. Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Burke & Boyer Nyc
Original Assignee
Burke & Boyer Nyc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burke & Boyer Nyc filed Critical Burke & Boyer Nyc
Publication of CA2963980A1 publication Critical patent/CA2963980A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA2963980A 2014-10-15 2015-10-14 Monounsaturated fatty acid compositions and use for treating atherosclerosis Abandoned CA2963980A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462064207P 2014-10-15 2014-10-15
US62/064,207 2014-10-15
PCT/US2015/055504 WO2016061207A1 (en) 2014-10-15 2015-10-14 Monounsaturated fatty acid compositions and use for treating atherosclerosis

Publications (1)

Publication Number Publication Date
CA2963980A1 true CA2963980A1 (en) 2016-04-21

Family

ID=55747261

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2963980A Abandoned CA2963980A1 (en) 2014-10-15 2015-10-14 Monounsaturated fatty acid compositions and use for treating atherosclerosis

Country Status (8)

Country Link
US (1) US9808437B2 (enExample)
EP (1) EP3206677A4 (enExample)
JP (2) JP6840671B2 (enExample)
CN (2) CN106794165A (enExample)
BR (1) BR112017007754B1 (enExample)
CA (1) CA2963980A1 (enExample)
MX (1) MX2017004839A (enExample)
WO (1) WO2016061207A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7602315B2 (ja) * 2018-10-16 2024-12-18 株式会社ニッスイ 血清中ｔｍａｏ低減用組成物
EP4017484A4 (en) * 2019-08-21 2022-10-19 Burke & Boyer, Inc. MONOUNSATURATED FATTY ACID COMPOSITION AND USE TO TREAT FAT LIVER DISEASE
EP4351362A4 (en) * 2021-06-11 2025-04-23 Nourish Ingredients Pty Ltd Production of saturated fats in microbes
CN118251135A (zh) * 2021-06-11 2024-06-25 营养成分私人有限公司 微生物中饱和脂肪的产生

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
US6183796B1 (en) * 1999-09-20 2001-02-06 Lipotech Partners Limited Partnership Monounsaturated fatty acid compositions and method of making
AU2007230989A1 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis
US20090311367A1 (en) 2008-06-17 2009-12-17 Perry Stephen C Dietary Supplement
DK2384192T3 (en) * 2009-01-05 2018-01-08 Calanus As BIOLOGICAL OIL COMPOSITION, FORMULATIONS CONTAINING THE OIL COMPOSITION, AND ITS USE TO PREVENT OR TREAT CARDIOVASCULAR DISEASE
JP6206937B2 (ja) * 2010-10-08 2017-10-04 和久 前田 マッサージ施療による経皮投与用の血流依存性血管拡張反応改善剤及び血糖値低下剤、並びに生体用貼付シート
JP2014518609A (ja) 2011-03-03 2014-08-07 テルサス ファーマシューティカルズ リミテッド ライアビリティ カンパニー Ｃ１６：１ｎ７−パルミトレアートを含む組成物および方法
ITMI20111284A1 (it) 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
WO2014054048A1 (en) * 2012-10-01 2014-04-10 Dow Global Technologies Llc Triglyceride based, low viscosity, high flash point dielectric fluids

Also Published As

Publication number Publication date
US9808437B2 (en) 2017-11-07
EP3206677A4 (en) 2018-04-25
MX2017004839A (es) 2017-10-12
US20170216237A1 (en) 2017-08-03
BR112017007754B1 (pt) 2023-04-11
JP6840671B2 (ja) 2021-03-10
WO2016061207A1 (en) 2016-04-21
CN113244206A (zh) 2021-08-13
JP2020182497A (ja) 2020-11-12
EP3206677A1 (en) 2017-08-23
BR112017007754A2 (pt) 2018-08-28
JP2017532381A (ja) 2017-11-02
CN106794165A (zh) 2017-05-31

Similar Documents

Publication Publication Date Title
KR0126286B1 (ko) 지방산 조성물
EP0347056B1 (en) Essential fatty acid compositions
US6667064B2 (en) Composition and method for treatment of hypertriglyceridemia
US20080113046A1 (en) Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients
SE448678B (sv) Farmaceutisk beredning som vesentligen bestar av eikosapentaensyra eller derivat derav
SK10802001A3 (sk) Esenciálne mastné kyseliny na prevenciu kardiovaskulárnych príhod
JP2020182497A (ja) 一価不飽和脂肪酸組成物およびアテローム性動脈硬化症を処置するための使用
JP5932111B2 (ja) バイオオイル組成物、上記オイル組成物を含む製剤と、循環器疾患の予防又は治療のためのその使用
JPS62265222A (ja) 細胞膜の脂質構造および機能の修飾法並びにこれに使用する製剤組成物
WO2000032210A1 (de) Pharmazeutische zusammensetzung enthaltend fischöl, vitamin e und c und acetylsalicylsäure gegen arteriosklerose
WO2017191838A1 (ja) 安全・安定なプラズマローゲンとその製剤及び認知症の未病状態の判定方法
JPH0336493B2 (enExample)
US20200085774A1 (en) Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
HK40057957A (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
JP4167849B2 (ja) 植物の果実から抽出した果実油、その抽出方法、医薬組成物およびその用途
JPH01156922A (ja) 悩疾患治療用薬剤の製造方法と治療用化合物
JPH04244023A (ja) ω６系不飽和脂肪酸含有薬剤
JP2000239168A (ja) 脳卒中予防剤およびこれを配合してなる組成物
JP3816545B2 (ja) 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物
CA3148686A1 (en) Monounsaturated fatty acid composition and use for treating fatty liver disease
HK1238139A1 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
JP2000281572A (ja) 殺癌細胞剤及びこれを配合してなる組成物
JP4473968B2 (ja) 血球流動性改善剤
JP2005247871A (ja) 人工透析患者の副甲状腺機能亢進症治療組成物
WO2015185240A1 (en) Compositions containing simvastatin in omega-3 polyunsaturated fatty acids

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20201014

FZDE Discontinued

Effective date: 20230414